Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

McMaster University

$210,000.00

Identifying and characterizing novel fungal-derived inhibitors of bacterial vitamin biosynthesis

FY 2024-25

Summary
Antimicrobial resistance is a global health crisis that is putting a major strain on healthcare systems around the world, including here in Canada. Unfortunately, antibacterial drug discovery has not kept up with the rapid emergence of antibiotic resistance in bacteria. With a limited antibiotic pipeline, new antibiotics must be discovered to meet the growing clinical demand. Antibiotics targeting essential processes such as DNA replication, RNA synthesis and protein synthesis have been exhausted, warranting new targets and novel approaches to be explored. Bacterial nutrient biosynthesis becomes essential in the host where vitamins, amino acids and nucleobases are not readily available. As such, nutrient biosynthesis represents a promising and historically underappreciated antibiotic target. Additionally, despite clinically used antibiotics such as penicillin and cephalosporins being produced by fungi, fungi are an understudied and underappreciated source of antibacterial metabolites. This project aims to understand the antimicrobial potential of fungi and identify novel fungal-derived nutrient biosynthesis inhibitors. Using a collection of diverse fungal extracts (n=~5340), Escherichia coli, Staphylococcus aureus and Saccharomyces cerevisiae will be profiled to identify extracts that prevent growth in nutrient-limited media. Any extracts that exhibit antibacterial activity will be further profiled using genetic and chemical assays to determine the target pathway and mechanism of action. The goal of this project is to identify and characterize novel fungal metabolites that target essential vitamin biosynthesis pathway(s). Overall, this work would highlight the previously unknown antimicrobial potential that fungi possess. Furthermore, identifying novel vitamin biosynthesis inhibitors as candidate antimicrobial compounds would have a significant impact on the fight against antimicrobial resistance.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
513417
Name
Leonard Allison
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Identifying and characterizing novel fungal-derived inhibitors of bacterial vitamin biosynthesis
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$210,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Antimicrobial; Bacteria; Drug Discovery; Fungi; High-Throughput
Abstract
Antimicrobial resistance is a global health crisis that is putting a major strain on healthcare systems around the world, including here in Canada. Unfortunately, antibacterial drug discovery has not kept up with the rapid emergence of antibiotic resistance in bacteria. With a limited antibiotic pipeline, new antibiotics must be discovered to meet the growing clinical demand. Antibiotics targeting essential processes such as DNA replication, RNA synthesis and protein synthesis have been exhausted, warranting new targets and novel approaches to be explored. Bacterial nutrient biosynthesis becomes essential in the host where vitamins, amino acids and nucleobases are not readily available. As such, nutrient biosynthesis represents a promising and historically underappreciated antibiotic target. Additionally, despite clinically used antibiotics such as penicillin and cephalosporins being produced by fungi, fungi are an understudied and underappreciated source of antibacterial metabolites. This project aims to understand the antimicrobial potential of fungi and identify novel fungal-derived nutrient biosynthesis inhibitors. Using a collection of diverse fungal extracts (n=~5340), Escherichia coli, Staphylococcus aureus and Saccharomyces cerevisiae will be profiled to identify extracts that prevent growth in nutrient-limited media. Any extracts that exhibit antibacterial activity will be further profiled using genetic and chemical assays to determine the target pathway and mechanism of action. The goal of this project is to identify and characterize novel fungal metabolites that target essential vitamin biosynthesis pathway(s). Overall, this work would highlight the previously unknown antimicrobial potential that fungi possess. Furthermore, identifying novel vitamin biosynthesis inhibitors as candidate antimicrobial compounds would have a significant impact on the fight against antimicrobial resistance.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Leonard, Allison
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $210,000~ $0~
McMaster University - $210,000 Grant (2024-25) | Canada Spends